Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy.
about
Vaccination of Adult Patients with Systemic Lupus Erythematosus in PortugalGastrointestinal cytomegalovirus disease in a patient with pemphigus vulgaris treated with corticosteroid and mycophenolate mofetilProtective effect of the HLA-DRB1*13:02 allele in Japanese rheumatoid arthritis patients.Infection and Lupus: Which Causes Which?Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients.Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01.Is There a Role for Opportunistic Infection Prophylaxis in Pemphigus? An Expert Survey.Listeria monocytogenes Meningitis in an Immunosuppressed Patient with Autoimmune Hepatitis and IgG4 Subclass Deficiency.Sarcoidosis Increases Risk of Hospitalized Infection. A Population-based Study, 1976-2013.Clinical Relevance of Steroid Use in Neuro-Oncology.Transcriptomic Analysis Reveals Significant B Lymphocyte Suppression in Corticosteroid-Treated Hosts with Pneumocystis Pneumonia.A genome-wide DNA methylation analysis in peripheral blood from patients identifies risk loci associated with Graves' orbitopathy.Diabetes and the occurrence of infection in primary care: a matched cohort study.Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study
P2860
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
P2860
Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Rates of serious intracellular ...... nitial glucocorticoid therapy.
@en
type
label
Rates of serious intracellular ...... nitial glucocorticoid therapy.
@en
prefLabel
Rates of serious intracellular ...... nitial glucocorticoid therapy.
@en
P2093
P2860
P1433
P1476
Rates of serious intracellular ...... nitial glucocorticoid therapy.
@en
P2093
Eiichi Suematsu
Fumitaka Ogushi
Haruhiro Yamashita
Hideo Nishimura
Hideyuki Sawada
Hiroaki Iwase
Hiroshi Furukawa
Hiroshi Tsutani
Kenji Kawakami
Kiyoshi Migita
P2860
P304
P356
10.1371/JOURNAL.PONE.0078699
P407
P577
2013-11-19T00:00:00Z